Assaying the Effect of Levodopa on the Evaluation of Risk in Healthy Humans

Open Access

Peer-reviewed

Research Article

Mkael Symmonds ,

* E-mail: mkael.symmonds@googlemail.com

Affiliations Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, United Kingdom, Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom
⨯
Nicholas D. Wright,

Affiliation Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, United Kingdom
⨯
Elizabeth Fagan,

Affiliation Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, United Kingdom
⨯
Raymond J. Dolan

Affiliation Wellcome Trust Centre for Neuroimaging, Institute of Neurology, University College London, London, United Kingdom
⨯

Reader Comments (0)

Medical risk factors
Is the Subject Area "Medical risk factors" applicable to this article?

Thanks for your feedback.
Dopamine
Is the Subject Area "Dopamine" applicable to this article?

Thanks for your feedback.
Decision making
Is the Subject Area "Decision making" applicable to this article?

Thanks for your feedback.
Skewness
Is the Subject Area "Skewness" applicable to this article?

Thanks for your feedback.
Levodopa
Is the Subject Area "Levodopa" applicable to this article?

Thanks for your feedback.
Gambling
Is the Subject Area "Gambling" applicable to this article?

Thanks for your feedback.
Experimental economics
Is the Subject Area "Experimental economics" applicable to this article?

Thanks for your feedback.
Learning
Is the Subject Area "Learning" applicable to this article?

Thanks for your feedback.